Breakthrough in synthesis advances a potent anti-cancer agent
News
"Unprecedented achievement" provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway By Caroline Perry, Office of Technology Development It's a feat three decades in the making: Harvard University chemists...